The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Thienamycin: development of imipenem-cilastatin
Abstract
Thienamycin, a natural product produced by Streptomyces cattleya is the first representative of a unique class of beta-lactam antibiotics, the carbapenems. Despite its outstanding potency and antibacterial spectrum, thienamycin was itself unsuited for further development because of its chemical instability in concentrated solution and in the solid state. Synthesis of the amidine derivative, N-formimidoyl thienamycin (imipenem, MK0787) resulted in a crystalline product with much improved stability and with antibacterial properties significantly superior to thienamycin. Imipenem has an unusually broad antimicrobial spectrum. A high order of bactericidal activity is found against Pseudomonas aeruginosa, Serratia, Bacteroides fragilis, enterococci and numerous other species intrinsically resistant to other antibiotics. Imipenem is refractory to hydrolysis by all important classes of bacterial beta-lactamases and thus exhibits no cross-resistance with penicillins or cephalosporins. Imipenem is distinguished from the new generation of extended-spectrum cephems by its unusually high potency against Gram-positive as well as Gram-negative organisms. Offsetting these excellent antimicrobial properties was an unusual susceptibility exhibited by imipenem to renal metabolism in animal species and in man. Very low urinary recoveries resulted without, however, any significant reduction in the serum half-life of imipenem. A brush-border dipeptidase, dehydropeptidase-I, was shown to be responsible for renal metabolism. Metabolism has been countered with the development of cilastatin (MK0791), a substituted amino-propenoate inhibitor of dehydropeptidase which is specific, potent and well matched in its pharmacokinetic properties for co-administration with imipenem. With the imipenem/cilastatin combination, uniformly high urinary concentrations and recovery are obtained regardless of the varying but often extensive metabolism suffered by imipenem in human populations. An additional benefit conferred by cilastatin results from its ability to exclude imipenem competitively from entry into and subsequent metabolism within the proximal tubular epithelium of the kidney. The tubular necrosis induced by imipenem alone when it is administered at very high doses to susceptible mammalian species is thereby eliminated. Thus the imipenem/cilastatin combination affords reliability and enhanced safety in the application of the antibiotic's unusual antibacterial potential in the treatment of difficult infections regardless of the site of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective Modification of Glutathione Metabolism
Meister, A. (1983) · Science · doi:10.1126/science.6836290 · Cited by 1,267
Properties of the Penicillin‐Binding Proteins of Escherichia coli K12
SPRATT, B. G. (1977) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1977.tb11258.x · Cited by 631
KAHAN, J. S., KAHAN, F. M., GOEGELMAN, R., CURRIE, S. A., JACKSON, M., STAPLEY, E. O., MILLER, T. W., MILLER, A. K., HENDLIN, D., MOCHALES, S., et al. (1979) · The Journal of Antibiotics · doi:10.7164/antibiotics.32.1 · Cited by 514
Self-citationKropp, H., Sundelof, J. G., Hajdu, R., & Kahan, F. M. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.1.62 · Cited by 339
Self-citationStructure and absolute configuration of thienamycin
Albers-Schoenberg, G., Arison, B. H., Hensens, O. D., Hirshfield, J. M., Hoogsteen, K., Kaczka, E. A., Rhodes, R. E., Kahan, J. S., & Kahan, F. M. (1978) · Journal of the American Chemical Society · doi:10.1021/ja00488a038 · Cited by 299
Self-citationSaino, Y., Kobayashi, F., Inoue, M., & Mitsuhashi, S. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.22.4.564 · Cited by 233
Ishino, F., & Matsuhashi, M. (1981) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(81)91835-0 · Cited by 175
ADVANCES IN ENZYMOLOGY AND RELATED SUBJECTS OF BIOCHEMISTRY
(1966) · Elsevier eBooks · doi:10.1016/b978-0-08-012210-6.50012-0 · Cited by 148
Spratt, B. G., Jobanputra, V., & Zimmermann, W. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.12.3.406 · Cited by 110
Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall
Krogstad, D. J., & Pargwette, A. R. (1980) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.17.6.965 · Cited by 100
Richmond, M. H. (1981) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/7.3.279 · Cited by 55
Verbist, L., & Verhaegen, J. (1981) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.19.3.402 · Cited by 43
Markowitz, N. P., Pohlod, D. J., Saravolatz, L. D., & Quinn, E. L. (1983) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.23.3.450 · Cited by 42
Inhibition of Transpeptidase Activity in Escherichia coli by Thienamycin
Moore, B. A., Jevons, S., & Brammer, K. W. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.15.6.831 · Cited by 7
Cited by
Åkerman, M. E., Chan, W. C. W., Laakkonen, P., Bhatia, S. N., & Ruoslahti, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152463399 · Cited by 1,437
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Talele, T. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00472 · Cited by 1,023
Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?
von Nussbaum, F., Brands, M., Hinzen, B., Weigand, S., & Häbich, D. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600350 · Cited by 672
β-lactam antibiotics: An overview from a medicinal chemistry perspective
Lima, L. M., Silva, B. N. M. D., Barbosa, G., & Barreiro, E. J. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112829 · Cited by 642
Metadata
- Authors
- Kahan, F. M., Kropp, H., Sundelof, J. G., & Birnbaum, J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 1983-01-01
- Volume
- 12
- Issue
- suppl D
- Pages
- 1-35
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W1991546041
- Cited by
- 313
- References
- 14
- FWCI
- 22.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.